- PillCam COLON is intended for visualization of the colon
- Patients with known or suspected GI obstruction, strictures, or fistulas based on the clinical picture or pre-procedure testing and profile
- Patients with cardiac pacemakers or other implanted electro-medical devices
- Patients with swallowing disorders
There is a risk of capsule retention associated with PillCam capsule endoscopy procedures. Capsule retention is defined as having a capsule that remains in the digestive tract for more than two weeks.
In cases where the patient fails to see passage of the capsule or the study does not show a clear exit of the capsule to the cecum, an x-ray may verify if the capsule is retained.
There is a rare risk of capsule aspiration while patients are attempting to swallow a PillCam capsule. There is also a low risk of skin irritation from the PillCam sensor array’s sleeve adhesive or silicone exposure.
After ingesting a PillCam capsule and until the capsule is excreted, patients should not be near any source of powerful electromagnetic fields, such as one created by an MRI device.
The risks associated with colon preparation are potential allergies or other known contraindication to any preparation agents or medications used for the PillCam COLON regimen, according to laxative medication labeling and per physician discretion. Medical, endoscopic, or surgical intervention may be necessary to address any of these complications, should they occur.
This information should not be used as a substitute for medical advice concerning specific diagnosis and treatment.